Loading data
ATNMNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 90 k USD | — | 81 k USD | 1.03 m USD | 1.14 m USD |
| Research and development expense | 21.12 m USD | 30.05 m USD | 38.67 m USD | 23.14 m USD | 18.03 m USD |
| Operating profit | -36.25 m USD | -42.12 m USD | -51.92 m USD | -34.1 m USD | -24.96 m USD |
| Net income (reported basis) | -33.89 m USD | -38.24 m USD | -48.82 m USD | -33.02 m USD | -24.77 m USD |
| Basic earnings per share | -1.09 USD/share | -1.27 USD/share | -1.83 USD/share | -1.37 USD/share | -1.2 USD/share |
| Diluted earnings per share | -1.09 USD/share | -1.27 USD/share | -1.83 USD/share | -1.37 USD/share | -1.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.